| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |